2Tumidge J, Bell J, Biedenbach D J, et al. Pathogen ocurrence and antimicmbia resistance trends amtmg urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Anfimicmbial Surveillanceogrddm [J]. 1998- 1999. Hat J Antimicrob Agents, 2002,20( 1 ) .. 10.
3Mingiot-Leclercq M P,Glupezynski Y,Tulkens P M. Amino- glycosides:activity and resistanee[J]. Antimicmb Agents Chemoth- er, 1999,43 : 727.
4Moore R D, Smith C R, Lietman P. Clinical response to ami- noglycoside therapy: Importance of theration of peak concentra- tion minimal inhibitory concentration[J]. J lnfeet Dis, 1987, 155: 93.
5Nightingale C H,Murakawa T,Ambrose P C,et al. Antimicro- bial pharmacodynamics in theory and clinical practice[J]. New York : Marcel Dekker, InC, 2002,385-408.
6Yano H, Kuga A, Okalnoto R, et al. Plasmid-encodextmetallo- 13-1actamase(IMP-6)conferring resistance to carbapenem,especially meropenem[J]. Antinficrob Agents Chemother,2001,45(5) : 1343.
10Aneliya M H,Nikolina V R,Parvan R P. Integration of Phar- macokinetic and Pharmacodynamic Indices of Marbotloxacin in Turkeys [J]. Antimicrob Agents Chemother, 2006, 50 (11) : 3779-3785.
二级参考文献35
1[2]北京协和医院药剂科译.抗微生物药物的药物动力学.北京:中国医药科技出版社,1997,80.
2[3]Thoma GV. Beta-lactam antibiotics: is continuous infusion the preferred method of administration? The Annals of Pharmacotherapy, 1995, 29: 415.
5[6]Zhao X, Drlica K. Restricting the selection of antibiotic resistant mutants: a general strategy derived form fluoro quinolone studies. Clini Infect Dis, 2001, 33 (suppl 3):S147.
6[7]Zhao X, J Drlica . Restricting the selection of antibiotic resistant mutant bacteria: measurement and potential use ofthe mutant selection window. The Journal of Infectious Diseases,2002, 35: 561.
7[8]Craig WA, Ebert SC. Killing and regrowth of bacteria in vitro. Scand J Infect Dis , Suppl 1991, 74: 63.
8[9]Ursula Fluckiger et. Integration of Pharmacokinetics and Phrmacodynamics of Imipenem in a Human -Adapted Mouse Model. Antimicrobiol Agents and Chemotherapy, 1991, 35: 1905.
9[10]Bennett Vogelman et. Kinetics of antimicrobiol activity. The Journal of Pediatric, 1986, 108: 835.
10[11]CraigWA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad- spectrum cephalosporins. Diagn Microbiol Infect Dis, 1995, 22: 89.
